Cargando…
Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue?
Luteal phase deficiency (LPD) is described as a condition of insufficient progesterone exposure to maintain a regular secretory endometrium and allow for normal embryo implantation and growth. Recently, scientific focus is turning to understand the physiology of implantation, in particular the sever...
Autores principales: | Palomba, Stefano, Santagni, Susanna, La Sala, Giovanni Battista |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653859/ https://www.ncbi.nlm.nih.gov/pubmed/26585269 http://dx.doi.org/10.1186/s13048-015-0205-8 |
Ejemplares similares
-
Complications and challenges associated with polycystic ovary syndrome: current perspectives
por: Palomba, Stefano, et al.
Publicado: (2015) -
Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review
por: Palomba, Stefano, et al.
Publicado: (2016) -
Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support
por: Beltsos, Angeline N, et al.
Publicado: (2014) -
Do early luteal serum progesterone levels predict the reproductive outcomes in IVF with oral dydrogesterone for luteal phase support?
por: Netter, Antoine, et al.
Publicado: (2019) -
Luteal Phase Support in assisted reproductive technology treatment: focus on Endometrin® (progesterone) vaginal insert
por: Check, Jerome H
Publicado: (2009)